We constructed a human pheochromocytoma cDNA library and used differential hybridization to human pheochromocytoma and human neuroblastoma cDNA probes to isolate genes that are highly expressed in the adrenal medullary neuroendocrine tumor, pheochromocytoma, but not in the more immature embryonal tumor of adrenal medulla, neuroblastoma. Two cDNA clones, pG8 and pG2, were more highly expressed in normal and neoplastic chromaffin tissue than they are in neuroblastoma. Furthermore, they are expressed in a remarkably limited number of other human tumors or normal tissues. pG8 is highly expressed in medullary thyroid carcinoma, another tumor of neural crest origin, which can occur in association with pheochromocytoma in the multiple endocrine neoplasia type II syndrome. pG2 is highly expressed in the adrenal cortex, an endocrine gland thought to be embryologically unrelated to the neural crest-derived adrenal medulla. The expression of both pG8 and pG2 can be induced in human neuroblastoma cells with dexamethasone, suggesting a mechanism by which glucocorticoids may influence development of a neuroendocrine phenotype.
Provocative evidence suggests that environmental influences play an important role in the differentiation of embryonal neural crest precursors. These precursors give rise to a remarkable diversity of differentiated tissues including both neural, neuroendocrine, and nonneuronal tissues (1) (2) (3) (4) . These are distinguished by both morphologic and biochemical criteria. We have characterized genes whose expression is regulated during the differentiation of neuroendocrine tissues arising from primitive neural crest cells and identified a regulatory mechanism by which an environmental influence likely to be of physiologic significance may be mediated.
To identify genes expressed during the differentiation of neuroendocrine tissues, we constructed a human pheochromocytoma cDNA library and used differential hybridization to identify cDNA clones that might correspond to genes highly expressed in pheochromocytoma but not in neuroblastoma. Pheochromocytoma is a tumor of the adrenal medulla that typically appears morphologically and ultrastructurally indistinguishable from neuroendocrine tissue found in the normal adrenal medulla (5) . This tumor tissue bears all the neuroendocrine markers of mature adrenal medullary tissue and occurs during adulthood. Neuroblastoma is also a tumor of the adrenal medulla and occurs during early childhood. This tumor has a very undifferentiated appearance and is thought to arise from embryonal neural crest tissue that may be arrested at an early stage of differentiation (6) .
Differentiation within the sympathoadrenal lineage of the neural crest is of particular interest since more is known about development within this pathway than about the differentiation of other neural crest-derived tissues. An early decision within this lineage is the choice between the neuronal and neuroendocrine phenotypes. Many studies have suggested that nerve growth factor (NGF) and glucocorticoids have important and opposing influences on this decision (2, (7) (8) (9) . In this study we have identified specific genes where regulation by such environmental influences contribute to the differentiated features of chromaffin tissue.
MATERIALS AND METHODS
Construction of a cDNA Library. Total cellular RNA was prepared from a human pheochromocytoma tumor by using the guanidinium thiocyanate/cesium chloride procedure (10) . Poly(A)+ RNA was isolated by oligo(dT)-cellulose selection (11) . Double-stranded cDNA was prepared by the method of Gubler and Hoffman (12) with 2 ,ug of poly(A)+ RNA as a template. cDNA was cloned into the plasmid pUC9 by G-C tailing (13) . Approximately 10,000 ampicillin-resistant Escherichia coli, strain RRI, colonies were subsequently screened with cDNA probes as described below.
cDNA Probes. 32P-labeled cDNA probes were prepared from poly(A)+ RNA isolated from a human neuroblastoma cell line [SMS-KCNR (14) ] and a human pheochromocytoma tumor by using the method for first-strand cDNA synthesis described above except that the concentration of labeled nucleotide was 36 AM. The specific activity of these cDNA preparations was greater than 1 x 108 cpm/,g (15, 16) .
Library Screening. Recombinant clones were plated directly onto colony/plaque screen filters (New England Nuclear). Duplicate lifts were made from these master filters and screened by previously described methods (13, 17, 18) . One filter of each set was then hybridized with a 32P-labeled neuroblastoma cDNA or a 32P-labeled pheochromocytoma cDNA probe. Hybridization with the cDNA probes was carried out for 24 hr at 65°C in 1 M NaCl/50 mM Tris, pH 7.4/1% NaDodSO4 containing 250 ,g of sonicated denatured salmon sperm DNA and 3 x 105 cpm of cDNA probe per ml. The filters were washed in 2 x NaCl/Cit (lx = 0.15 M NaCl/0.015 M sodium citrate, pH 7.0) containing 1% NaDodSO4 at 65°C for 1 hr, followed by 0.1 x NaCl/Cit at room temperature for 1 hr. Clones hybridizing exclusively to the pheochromocytoma cDNA probe were picked, grown in 96-well plates, and replica-plated onto nitrocellulose. These filters were subjected to a second round of differential hybridization to the pheochromocytoma and neuroblastoma cDNA probes. Hybridization on nitrocellulose was carried out at 65°C in 6x NaCl/Cit containing 5x Denhardt 
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vine serum albumin), 75 ,ug of sonicated salmon sperm DNA per ml, 0.1% NaDodSO4, and 5 x 105 cpm/ml of 32P-labeled cDNA probe. The final wash was with 0.2x NaCl/Cit/0.1% NaDodSO4 at 650C for 30 min.
Blot-Hybridization Analysis. Total cellular RNA was prepared from human tissues and cell lines by using the guanidinium thiocyanate/cesium chloride procedure (10) . The RNA was size-fractionated on 1% agarose/6% formaldehyde gels after denaturation by heating at 650C for 5 min in 50% (vol/vol) formamide/6% (vol/vol) formaldehyde/20 mM 4-morpholinepropanesulfonic acid/5 mM NaOAc/1 mM EDTA. The fractionated RNA was then transferred to Nytran (Schleicher and Schuell) and hybridized for 16 hr to in vitro 32P-labeled pG2 or pG8 DNA (specific activity, >1 x 108 cpm/,ug) in 50% (vol/vol) formamide/5x NaCl/Cit/lx Denhardt's solution/0.1% NaDodSO4/100 ug of sonicated salmon sperm DNA per ml. The final hybridization wash was 0.1x NaCl/Cit/1% NaDodSO4 at 65°C for 1 hr. Blots were stripped in 50%o formamide/1 x NaCl/Cit at 75°C for 1 hr.
In Vitro Dexamethasone Treatment of a Neuroblastoma Cell Line. LA-N-5 neuroblastoma cells (2 x 106; ref. 19) were plated in 150 x 25 mm tissue culture dishes in RPMI 1640 with 15% fetal bovine serum. After 24 hr, the medium was removed and replaced by medium containing 1 or 100 nM dexamethasone (Sigma) dissolved in sterile water or by a control medium with sterile water alone. Cells were plated in duplicate and maintained for 7 days under these conditions with one change of media during the experimental period. After 7 days, total RNA was extracted and evaluated by blot-hybridization analysis. 
RESULTS
Isolation and Characterization of cDNA Clones. To identify genes expressed at a much higher level in differentiated neuroendocrine tissues than in embryonal neuroendocrine tissues, about 10,000 clones derived from a human pheochromocytoma cDNA library were screened by differential hybridization to 32P-labeled pheochromocytoma and neuroblastoma cDNA probes. Among the clones isolated in this screening, two independent clones, pG2 and pG8, were found to be highly expressed in pheochromocytoma but not in neuroblastoma.
To characterize the pattern of pG8 and pG2 expression in human tissues, we used these DNA clones as molecular probes for blot-hybridization analysis of total cellular RNA isolated from a variety of normal and neoplastic tissues (Fig.  1) . pG8 recognized an RNA species of approximately 2.1 kilobases (kb) in pheochromocytoma and normal adrenal medulla (Fig. 1A) . No signal was detected in normal human muscle, kidney, spleen, brain, cultured fibroblasts or in other human tumors of neural, neural crest, or lymphoid origin. RNA preparations from these same tissues were examined on another blot for the expression of pG2 (Fig. 1B) . We found that pG2 recognized an RNA species of approximately 1.6 kb with a pattern of distribution identical to that observed for pG8. Ofparticular interest is our evaluation of the expression of pG2 and pG8 in neuroblastoma. We examined eight neuroblastoma tumor cell lines as well as two neuroblastoma tumor tissues and invariably found either no detectable expression or very low levels of expression compared to that observed in pheochromocytoma (data not shown). tively, demonstrating that comparable amounts of intact RNA were loaded into each lane. We subsequently analyzed multiple specimens of many additional human carcinomas, sarcomas, and normal tissues and did not detect expression of either pG2 or pG8 in any other malignant or normal human tissue other than known neuroendocrine tissues, except for expression of pG2 in adrenal cortex (see below).
Expression of pG2 and pG8 in Normal and Neoplastic Neuroendocrine Tissue. Neuroendocrine tissues arising from the mammalian neural crest are concentrated in a number of paraganglia that are distributed throughout the body. Most paraganglia are extremely small. The largest collection of such paraganglia makes up the adrenal medulla (21) . To examine the expression of pG8 and pG2 in normal neuroendocrine tissue, we separated the adrenal cortex, a mesodermally derived endocrine tissue that secretes a variety of steroid hormones, from the adrenal medulla, an ectodermally derived neuroendocrine tissue that secretes catecholamines, and examined pG8 and pG2 expression in these tissues. Expression of pG8 could be detected at high levels in adrenal medulla (Fig. 1C, lanes 3-5) but not in adrenal cortex (Fig.  1C, lanes 1, 2, and 6 ). RNA preparations in Fig. 1C , lanes 1-4 were from four different adrenals, while the RNA preparations in lanes 5 and 6 were from the same adrenal gland. Fig.  1D shows the same blot used in Fig. 1C after removal of the pG8 probe and rehybridization to 32P-labeled pG2 DNA. In this case, expression was detected not only in adrenal medulla but also in adrenal cortex.
To examine the expression of pG2 and pG8 in other paraganglionic tissue, we evaluated neoplastic paragangliomas for the expression of these genes. Fig. 2A shows the results of a blot-hybridization analysis of nine paragangliomas (two malignant and six benign pheochromocytomas and one urinary bladder paraganglioma) for the expression of pG8. Fig. 2B is the same blot shown in Fig. 2A after removal of the pG8 probe and rehybridization with 32P-labeled p02 DNA. We found that RNA corresponding to each of these genes were highly expressed in all nine paragangliomas examined.
Expression of pG8 in Medullary Thyroid Carcinoma. Other than adrenal medullary cells and microscopic collections of paraganglionic cells in organs such as the carotid bodies, the only endocrine tissue clearly established to be of neural crest origin is the calcitonin-secreting 'C cell" of the thyroid gland (22) . Tumors of C cells are known as medullary thyroid carcinomas (MTC) and occur both sporadically and in association with pheochromocytoma in the familial disorder multiple endocrine neoplasia syndrome type II (MEN II) (23) . We therefore evaluated MTC tumors, both sporadic and A pG8 1 2 3 4 5 6 7 8 9 28s -f 18s --' o~. MEN II-associated, for the expression of pG2 and pG8. Blot-hybridization analysis of five MTC tumors showed a high level of pG8 expression in all five tumors (Fig. 3) . We examined a total of 10 such tumors and found expression of this gene in all but 1. In contrast, pG2 expression was not detected in these tumors (data not shown). Induction of pG2 and pG8 Expression with Glucocorticoids. The location ofthe adrenal medulla within the adrenal cortex, the major physiologic source of glucocorticoids, and the possibility that glucocorticoids may be important for expression of the adrenal chromaffin phenotype (2, 7-9)-suggested that the high concentration of glucocorticoids in the environment of the adrenal medulla (25) may mediate molecular events important for the differentiation of cells located in the adrenal medulla. Therefore, we examined the ability of glucocorticoids to induce the expression of pG2 and pG8 in neuroblastoma cells, since these cells presumably arise within the sympathoadrenal lineage prior to terminal differentiation along a neuroendocrine pathway (6) and may be expected to retain considerable developmental plasticity. For these experiments, we chose a neuroblastoma cell line that had a low but detectable level of pG2 and pG8 expression prior to treatment with dexamethasone. Fig. 4 illustrates the stimulation of both pG8 and pG2 expression in neuroblastoma cells after incubation in dexamethasone for 1 wk. Densitometry tracings normalized to actin show an 8-to 9-fold increase in expression of pG2 and pG8 in these cells after exposure to 100 nM dexamethasone. We have subsequently repeated these experiments with a second neuroblastoma cell line with similar results (data not shown). The treatment of several breast carcinoma cell lines known to have steroid receptors with concentrations of dexamethasone up to 10 AM did not induce expression of these genes (data not shown).
DISCUSSION
Our results indicate that pG2 and pG8 encode RNAs that are highly expressed in both normal and neoplastic neuroendocrine tissues but not in a primitive tumor of sympathoadrenal lineage, neuroblastoma, or in mature neuronal tissue such as brain. In addition, pG8 is highly expressed in another neural crest derived neuroendocrine tumor, MTC. We detected pG8 expression in both sporadic MTC as well as in MTC tumors which are genetically linked to pheochromocytoma in the MEN II syndrome. Therefore, we believe that pG8 expression specifically identifies cells differentiated along a neuro- endocrine pathway. Although both pheochromocytoma and MTC are derived from the neural crest, there are other neuroendocrine tumors, including gastrinomas, carcinoids, and oat cell carcinomas, collectively known as APUDomas, that are not derived from the neural crest (22) . An evaluation of the expression of pG8 in these tumors may be useful in clarifying whether pG8 expression identifies specifically neural crest-derived neuroendocrine tissue or neuroendocrine cells derived from any germ layer.
While expression of pG2 is limited uniquely to the adrenal gland, this gene was found to be highly expressed not only in pheochromocytoma and normal adrenal medulla but also in the adrenal cortex, an endocrine gland thought to be embryologically unrelated to the neural crest-derived adrenal medulla. The finding that pG8 expression is not detected in RNA preparations of adrenal cortex that express pG2 message (Fig. 1, lanes 1, 2, and 6 ) makes it unlikely that pG2 expression is due to adrenal medullary RNA contaminating the adrenal cortex RNA preparation. The detection of similar steady-state levels of RNA encoded by pG2 and pG8 in adrenal medulla provides further support for this interpretation ( Fig. 1; our unpublished data) . It is not known whether the adrenal cortical cells expressing pG2 are stromal, parenchymal, or simply migratory neural crest cells passing through the cortex, which have remained arrested there. It is possible that expression of pG2 is organ-specific rather than lineage-specific, although organ-specific genes have not been identified previously to our knowledge.
Neuroblastoma cells, which may correspond to sympathoadrenal cells arrested at an embryonal stage of development (6), respond to physiologic concentrations of glucocorticoids in vitro by increasing the expression of pG2 and pG8 RNAs. This finding indicates that the high local glucocorticoid environment of the adrenal medulla may therefore influence the differentiation of neural crest cells toward a neuroendocrine phenotype by causing an increase in expression of genes that mark this phenotype. Neuroblastoma cells have been shown previously to differentiate along a neuronal pathway in response to retinoic acid or NGF in vitro (26, 27) , and this neuronal differentiation is preceded by changes in levels of gene expression (28) . Preliminary experiments have suggested that neuroblastoma cells treated with retinoic acid or NGF have decreased levels of pG2 and pG8 RNA (our unpublished data). Therefore, it appears that NGF and glucocorticoids have opposing influences on the differentiation decisions of neuroblastoma in a manner analogous to their putative activities during physiological sympathoadrenal differentiation of neural crest cells (7) (8) (9) .
These observations provide an experimental framework for studying transcriptional alterations associated with differentiation along the sympathoadrenal lineage. Additionally, they support the concept that neuroblastoma arises in cells of sympathoadrenal lineage that are arrested prior to commitment along either a neuronal or neuroendocrine differentiation pathway. If differentiation arrest plays an etiological role in the development of neuroblastoma and closely related neural crest-derived tumors (6) , an understanding of the molecular mechanisms mediating developmental decisions within the sympathoadrenal lineage may lead to novel diagnostic approaches to the molecular classification of neuroendocrine tumors and therapeutic approaches focused upon the induction of differentiation in these embryonal tumors.
